Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	1 Months Ended	11 Months Ended	12 Months Ended
	Feb. 02, 2021	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ 268,777	$ (162,178)	$ 175,020	$ 286,465
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, depletion, amortization and accretion	10,499	251,361	81,068	98,060
Right-of-use assets amortization	1,372	8,380	2,825	6,357
Deferred income taxes	54,322	(48,975)	33,000	(104,587)
Stock-based compensation expense	935	2,710	4,123	4,807
Reorganization items, net	(354,279)	0	0	0
Bad debt	(210)	(4,908)	873	2,248
Gain on sale of assets and businesses	58	0	0	0
Gain on sale of equity securities	0	(383)	0	(8,950)
Unrealized gain on investment in equity securities	0	(2,147)	0	0
Other (gains) and losses, net	0	30,707	(13,520)	(32,872)
Loss on Blue Chip Swap securities	0	0	19,856	0
Washington State Tax Settlement	0	0	(27,068)	0
Decommissioning costs	0	0	(10,776)	0
Other reconciling items, net	(355)	6,687	(3,427)	(3,822)
Changes in operating assets and liabilities:
Accounts receivable	3,602	(28,676)	(30,168)	(65,669)
Prepaid expense	(340)	4,854	(1,958)	(1,096)
Inventory and other current assets	(221)	22,866	(28,153)	(4,568)
Accounts payable	(2,365)	735	2,015	(10,149)
Accrued expenses	23,489	(21,770)	(18,449)	8,503
Income taxes	340	11,535	5,318	771
Other, net	(241)	(11,914)	11,811	(82)
Net cash from operating activities	5,383	58,884	202,390	175,416
Cash flows from investing activities:
Payments for capital expenditures	(3,035)	(34,152)	(74,496)	(65,784)
Proceeds from sales of assets	775	97,505	31,099	50,376
Proceeds from sales of equity securities	0	4,099	0	34,685
Proceeds from sales of Blue Chip Swap securities	0	0	13,912	0
Purchases of Blue Chip Swap securities	0	0	(33,768)	0
Net cash from investing activities	(2,260)	67,452	(63,253)	19,277
Cash flows from financing activities:
Credit facility costs	(1,920)	(14)	0	0
Tax withholdings for vested restricted stock units	0	(1,485)	(1,116)	(135)
Distributions to shareholders	0	0	0	(249,986)
Net cash from financing activities	(1,920)	(1,499)	(1,116)	(250,121)
Effect of exchange rate changes on cash	311	0	0	0
Net change in cash, cash equivalents, and restricted cash	1,514	124,837	138,021	(55,428)
Cash, cash equivalents, and restricted cash beginning of period	268,184	269,698	339,107	394,535
Cash, cash equivalents, and restricted cash at end of period	$ 269,698	$ 394,535	$ 477,128	$ 339,107